Clinical Study of 18F Labeled Probe Targeting Fibroblast Activating Protein and Integrin avβ3 (FAPI-RGD) in Interstitial Lung Disease Associated With Connective Tissue Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to examine clinical utility of 18F-FAPI-RGD PET/CT imaging in evaluating connective tissue disease-associated interstitial lung disease. Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 and above

• Patients who have been diagnosed with, or are clinically highly suspected of ILD

• Patients who have been diagnosed with, or are clinically highly suspected of CTD-ILD

Locations
Other Locations
China
Sichuan Provincial People's Hospital
RECRUITING
Chengdu
Time Frame
Start Date: 2023-08-16
Estimated Completion Date: 2024-07
Participants
Target number of participants: 30
Sponsors
Leads: Sichuan Provincial People's Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials